Opaleye Management Inc. Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$191.1M
Holdings
44
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | 2L9BLUEPRINT MEDICINES CORP | 785,000 | $23.3M | 12.20% | |
| 2 | AXGNAXOGEN INC | 2,000,000 | $18.1M | 9.45% | |
| 3 | —ARIAD PHARMACEUTICALS INC | 1,045,000 | $14.3M | 7.49% | |
| 4 | —MEDGENICS INC | 1,800,000 | $10.0M | 5.25% | |
| 5 | AGIOAGIOS PHARMACEUTICALS | 130,000 | $6.9M | 3.59% | |
| 6 | FGENEURFIBROGEN INC | 330,000 | $6.8M | 3.57% | |
| 7 | —FOAMIX PHARMACEUTICALS LTD | 630,000 | $5.8M | 3.05% | |
| 8 | CARAEURCARA THERAPEUTICS INC | 675,000 | $5.6M | 2.95% | |
| 9 | CDXSCODEXIS INC | 1,170,000 | $5.2M | 2.72% | |
| 10 | —CYNAPSUS THERAPEUTICS INC | 125,000 | $5.0M | 2.63% | |
| 11 | —HORIZON GLOBAL CORP | 275,000 | $5.0M | 2.61% | |
| 12 | EGRXEAGLE PHARMACEUTICALS INC | 70,000 | $4.9M | 2.56% | |
| 13 | —IMPRIMIS PHARMACEUTICALS INC | 1,215,381 | $4.6M | 2.42% | |
| 14 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 200,000 | $4.6M | 2.41% | |
| 15 | —PROTALIX BIOTHERAPEUTICS INC | 8,070,000 | $4.6M | 2.41% | |
| 16 | MGNXMACROGENICS INC | 145,000 | $4.3M | 2.27% | |
| 17 | CMRXEURCHIMERIX INC | 780,000 | $4.3M | 2.26% | |
| 18 | —AQUINOX PHARMACEUTICALS INC | 310,000 | $4.1M | 2.17% | |
| 19 | —ADAMAS PHARMACEUTICALS INC | 250,000 | $4.1M | 2.15% | |
| 20 | —IMMUNOMEDICS INC | 1,200,000 | $3.9M | 2.04% | |
| 21 | —INOTEK PHARMACEUTICALS CORP | 400,000 | $3.8M | 1.98% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 410,000 | $3.3M | 1.74% | |
| 23 | PRTAPROTHENA CORP PLC | 50,000 | $3.0M | 1.57% | |
| 24 | —EDGE THERAPEUTICS INC | 280,000 | $2.9M | 1.53% | |
| 25 | —LOXO ONCOLOGY INC | 110,000 | $2.9M | 1.51% | |
| 26 | TREURTRILLIUM THERAPEUTICS INC | 175,000 | $2.6M | 1.35% | |
| 27 | —ZOGENIX INC | 220,000 | $2.5M | 1.32% | |
| 28 | CTMXCYTOMX THERAPEUTICS INC | 160,000 | $2.5M | 1.31% | |
| 29 | RAREULTRAGENYX PHARMACEUTICAL IN | 35,000 | $2.5M | 1.30% | |
| 30 | —PROTEOSTASIS THERAPEUTICS IN | 152,000 | $2.4M | 1.24% | |
| 31 | —LION BIOTECHNOLOGIES INC | 280,000 | $2.3M | 1.21% | |
| 32 | —CORIUM INTL INC | 400,000 | $2.3M | 1.18% | |
| 33 | AMRNAMARIN CORP PLC | 700,000 | $2.2M | 1.17% | |
| 34 | —NEURODERM LTD | 98,500 | $1.8M | 0.95% | |
| 35 | —NABRIVA THERAPEUTICS AG | 239,500 | $1.7M | 0.88% | |
| 36 | —INNOCOLL HLDGS PLC | 269,100 | $1.6M | 0.82% | |
| 37 | —AFFIMED N V | 430,000 | $1.2M | 0.63% | |
| 38 | —INTEC PHARMA LTD JERUSALEM | 175,000 | $1.0M | 0.54% | |
| 39 | —TENAX THERAPEUTICS INC | 390,000 | $905K | 0.47% | |
| 40 | —PORTOLA PHARMACEUTICALS INC | 35,000 | $795K | 0.42% | |
| 41 | —ABEONA THERAPEUTICS INC | 100,000 | $600K | 0.31% | |
| 42 | AMAGAMAG PHARMACEUTICALS INC | 15,000 | $368K | 0.19% | |
| 43 | —BIOLINERX LTD | 250,000 | $288K | 0.15% | |
| 44 | —DEPOMED INC | 1,650 | $41K | 0.02% |